ArticleScientific reports2025
Sleep architecture characteristics in patients with acute ischemic stroke.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum hypocretin, neurofilament heavy chain, and interleukin-1β as combined predictors of sleep disorders following acute ischemic stroke.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To investigate the changes in sleep architecture in patients with acute ischemic stroke (AIS) accompanied by sleep-disordered breathing (SDB), providing a basis for clinical treatment strategies. 1367 patients with acute ischemic stroke within 48 h of onset who were hospitalized in the Department of Neurology of Kailuan General Hospital from November 2020 to December 2022 were selected. Among them, 963 cases were male and 404 cases were female, age: 33-92 (66.12 ± 10.62) years old.From the start of hospitalization, patients were monitored for 5 consecutive days using the intelligent mattress type sleep monitoring platform system (IMTSMPS). From day 1 to day 5, there was a difference in non-rapid eye movement 3 (NREM3) sleep (min) day two, and day five compared to day one in the ACI without SDB group (p = 0.019), and rapid eye movement (REM) sleep (min) day three compared to day five in the ACI with SDB group (p = 0.001). TST (min), SL (min), WASO (min), TOB (min), NOA (min), HRV1, fluctuated between 5 d in mild SDB group (p < 0.05). SL (min), TOB (min), NOA (min), and HAV1(%) in the moderate SDB group, with fluctuations between 5 d (P < 0.05). TST (min), SL (min), REML(min), NREM3 (min), REM (min), proportion of REM sleep(%), TOB (min), NOA (min)in severe SDB group, there were fluctuations between 5 d (P < 0.05). SDB is one of the most common concomitant symptoms in AIS patients and is closely associated with multiple forms of altered sleep structure. AIS patients without SDB mainly showed changes in NREM3 sleep structure. AIS and SDB patients mainly showed changes in the structure of REM sleep. Different levels of SDB in AIS patients lead to different forms of structural changes in sleep.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.